CompletedPhase 2NCT04611425

REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nantes University Hospital
Principal Investigator
Raphaël CINOTTI, MD, M.D
Nantes University Hospital
Intervention
Remimazolam(drug)
Enrollment
30 enrolled
Eligibility
18-85 years · All sexes
Timeline
20202021

Study locations (1)

Collaborators

Paion UK Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04611425 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials